MYC and ovarian cancer: In addition, siRNA-mediated silencing of the histone deacetylase HDAC1 suppresses cell proliferation, increases apoptosis, and sensitizes ovarian cancer cells to cisplatin treatment by inducing c-MYC downregulation and miR-34a upregulation (101).